Patent Yard Sign in
Canadian application, no grantCanada

Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques

CA 2454784 A1 · Owner: Felici, Franco · Inventors: Felici, Franco; Minenkova, Olga

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A method is described for the identification of specific tumour antigens by means of the selection of cDNA display libraries by using sera characterised in that said selection is accomplished with the phage display technique and , in particular said selection is accomplished by means of the SEREX technique (serological analysis of autologous tumour antigens through the expression of recombinant cDNA). The method according to the invention described herein advantageously combines the SEREX approach with the potency of the phage display technique defined above, at the same time avoiding the drawbacks characteristic of the SEREX technique.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 25, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 25, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 25, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 25, 2002
GrantedNo grant recorded
Term endedJuly 25, 2022
Patent numberCA 2454784 A1
Classification (IPC)C07K16/30 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedJuly 25, 2002Term endedJuly 25, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.